Will Eledon Pharmaceuticals Inc (ELDN) Stay at the Top of the Healthcare Sector?

Eledon Pharmaceuticals Inc (ELDN) is around the top of the Healthcare sector according to InvestorsObserver. ELDN received an overall rating of 62, which means that it scores higher than 62% of stocks. Additionally, Eledon Pharmaceuticals Inc scored a 87 in the Healthcare sector, ranking it higher than 87% of stocks in that sector.

ELDN has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on ELDN!

See Full ELDN Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 62 means the stock is more attractive than 62 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Eledon Pharmaceuticals Inc Stock Today?

Eledon Pharmaceuticals Inc (ELDN) stock is down -12.19% while the S&P 500 has risen 0.3% as of 1:21 PM on Wednesday, Nov 1. ELDN has fallen -$0.19 from the previous closing price of $1.56 on volume of 138,476 shares. Over the past year the S&P 500 is up 9.08% while ELDN has fallen -44.08%. ELDN lost -$5.98 per share the over the last 12 months. Click Here to get the full Stock Report for Eledon Pharmaceuticals Inc stock.